Biologics X 3DCC Summit 2026: Where Innovation Meets Impact

Biologics X 3DCC Summit 2026 unites leading experts in biologics and 3D cell cultures to address challenges in drug development. This event encourages collaboration, aligning industry and academia with global trends to accelerate biopharma advancements and deliver accessible therapies worldwide.

The Mumbai Biocluster is set to host the Biologics X 3DCC Summit 2026 in collaboration with the Institute of Chemical Technology, Mumbai. This pivotal event merges two significant scientific conferences to unite experts in biologics, cell-based technologies, and translational research for a transformative dialogue.

The summit will attract over 800 global leaders who will engage in high-impact discussions and workshops. Events include a startup innovation showcase, scientific tracks, and a leadership forum. This collaborative effort aims to tackle bottlenecks in drug development and promote the effective use of advanced 3D cell culture technologies.

By fostering cross-sector collaboration, the summit aims to align Indian stakeholders with international regulatory trends, accelerating the adoption of human-relevant testing models and pioneering innovations in biopharma industries.

(With inputs from agencies.)